This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wienecke, R. Articles by DeClue, J. E. Search for Related Content PubMed PubMed Citation Articles by Wienecke, R. Articles by DeClue, J. E.

American Journal of Pathology, Vol 150, 43-50, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues

R Wienecke, JC Maize Jr, JA Reed, J de Gunzburg, RS Yeung and JE DeClue
Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland 20892, USA.

The tuberous sclerosis-2 (TSC2) gene is linked to tuberous sclerosis (TSC), a dominantly inherited genetic syndrome in which inactivation of the normal TSC2 allele is associated with the development of mostly benign tumors and focal dysplasias. TSC2 encodes the protein tuberin, which is a widely expressed 180-kd polypeptide that exhibits specific GTPase activating activity toward Rap1 in vitro and co-localizes with Rap1 in cultured cells. In this study, we have performed immunohistochemical analyses, using affinity-purified anti-tuberin antibodies, to study the distribution of tuberin in a panel of normal human organs that are commonly affected by TSC. Cryosections indicated that tuberin is widely expressed at low levels. More intense staining of tuberin, in the cryosections and in paraffin sections, was observed in the small blood vessels of many organs, including the kidney, skin, and adrenal gland. High levels of tuberin were also detected in cortical neurons and cerebellar Purkinje cells. These findings imply that loss-of-function mutations in TSC2 might lead to the development of highly vascularized tumors, subcortical tubers, and focal atrophy of the cerebellar cortex, which are features commonly associated with TSC. Moreover, Rap1 was also found to be highly expressed in many of the same cells that contained high levels of tuberin, suggesting a functional interaction between tuberin and Rap1 in these tissues.

This article has been cited by other articles:

				D. Clements, R. J. Mayer, and S. R. Johnson Subcellular distribution of the TSC2 gene product tuberin in human airway smooth muscle cells is driven by multiple localization sequences and is cell-cycle dependent Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L258 - L266. [Abstract] [Full Text] [PDF]

				P. B. Crino Molecular Pathogenesis of Tuber Formation in Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 716 - 725. [Abstract] [PDF]

				H.-S. Yoon, S. Ramachandiran, M. A. S. Chacko, T. J. Monks, and S. S. Lau Tuberous sclerosis-2 tumor suppressor modulates ERK and B-Raf activity in transformed renal epithelial cells Am J Physiol Renal Physiol, February 1, 2004; 286(2): F417 - F424. [Abstract] [Full Text] [PDF]

				J. L. Arbiser, B. Govindarajan, X. Bai, H. Onda, A. Kazlauskas, S. D. Lim, M. B. Amin, and L. Claesson-Welsh Functional Tyrosine Kinase Inhibitor Profiling : A Generally Applicable Method Points to a Novel Role of Platelet-Derived Growth Factor Receptor-{beta} in Tuberous Sclerosis Am. J. Pathol., September 1, 2002; 161(3): 781 - 786. [Abstract] [Full Text] [PDF]

				H.-S. Yoon, T. J. Monks, J. I. Everitt, C. L. Walker, and S. S. Lau Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity Am J Physiol Renal Physiol, August 1, 2002; 283(2): F262 - F270. [Abstract] [Full Text] [PDF]

				M. P. Schon, T. Ruzicka, R. Wienecke, I. Fackler, and P. Lehmann Multiple Eruptive Angiofibromas of the Trunk: Case Report of a New Entity? Arch Dermatol, November 1, 2001; 137(11): 1533 - 1535. [Full Text] [PDF]

				S. Duniho, F. Y. Schulman, A. Morrison, H. Mena, and A. Koestner A Subependymal Giant Cell Astrocytoma in a Cat Vet. Pathol., May 1, 2000; 37(3): 275 - 278. [Abstract] [Full Text] [PDF]

				M. H. Hyman and V. H. Whittemore National Institutes of Health Consensus Conference: Tuberous Sclerosis Complex Arch Neurol, May 1, 2000; 57(5): 662 - 665. [Full Text] [PDF]

				V. Murthy, L. A. Haddad, N. Smith, D. Pinney, R. Tyszkowski, D. Brown, and V. Ramesh Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney Am J Physiol Renal Physiol, May 1, 2000; 278(5): F737 - F746. [Abstract] [Full Text] [PDF]

				H. B. Samat and J. H. Menkes How to Construct a Neural Tube J Child Neurol, February 1, 2000; 15(2): 110 - 124. [PDF]

				P. B. Crino and E. P. Henske New developments in the neurobiology of the tuberous sclerosis complex Neurology, October 22, 1999; 53(7): 1384 - 1384. [Abstract] [Full Text] [PDF]

				H. Kurachi, Y. Wada, N. Tsukamoto, M. Maeda, H. Kubota, M. Hattori, K. Iwai, and N. Minato Human SPA-1 Gene Product Selectively Expressed in Lymphoid Tissues Is a Specific GTPase-activating Protein for Rap1 and Rap2. SEGREGATE EXPRESSION PROFILES FROM A rap1GAP GENE PRODUCT J. Biol. Chem., October 31, 1997; 272(44): 28081 - 28088. [Abstract] [Full Text] [PDF]